Drug Resistant Epilepsy: Clinical Trials

5 trials for Drug Resistant Epilepsy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown. 5 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Unknown 5
Phase 11Unknown 1

Follow Drug Resistant Epilepsy: new trials by email Literature Review of Drug Resistant Epilepsy trials Research Report on Drug Resistant Epilepsy

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy, Safety and Pharmacokinetics of ES-481 in Adult Patients With Drug Resistant Epilepsy
ES-481, Placebo, Open-Label Extension Study - Drug Resistant Epilepsy
Phase 2UnknownES Therapeutics Australia Pty Ltd242020-10-302023-03-02
Pilot Trial to Evaluate The Effect of Oral Methylprednisolone on Seizure Frequency in Children With Epilepsy
methylprednisolone sodium succinate, Placebo - Intractable Epilepsy, Convulsive Seizures
Phase 1 / Phase 2UnknownLouisiana State University Health Sciences Center in New Orleans102020-02-032020-02-07
Voronistat in Pediatric Patients With Drug Resistant Epilepsy
Vorinostat 100 MG - Refractory Epilepsy
Phase 2UnknownUniversity of Calgary122018-12-102019-03-29
Effect of Outpatient Classic Ketogenic Diet in Epileptic Children and Adolescent.
ketogenic diet - Refractory Epilepsy
Phase 2UnknownTehran University of Medical Sciences302016-07-012017-01-25
Efficacy and Safety of Ketogenic Diet as Adjunctive Treatment in Adults With Refractory Epilepsy
ketogenic diet - Epilepsy
Phase 2UnknownMid-Atlantic Epilepsy and Sleep Center, LLC302013-01-012018-02-23

Narrower conditions

Epilepsy (2)  ·  Seizures (1)

Broader conditions

Brain Diseases (5)  ·  Central Nervous System Diseases (5)  ·  Nervous System Diseases (5)  ·  Epilepsy (3)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Diet, Ketogenic (2)  ·  Methylprednisolone Hemisuccinate (1)  ·  Vorinostat (1)

Sponsors

ES Therapeutics Australia Pty Ltd (1)  ·  Louisiana State University Health Sciences Center in New Orleans (1)  ·  Mid-Atlantic Epilepsy and Sleep Center, LLC (1)  ·  Tehran University of Medical Sciences (1)  ·  University of Calgary (1)

Countries

United States (2)  ·  Australia (1)  ·  Canada (1)  ·  Iran (1)

Top investigators

Jeremy Toler, MD (1)  ·  Jong Rho, MD (1)  ·  Maryam Mahmoudi, MD, PHD (1)  ·  Pavel Klein, MD (1)  ·  Terence O'Brien (1)

Results publications

PMID 29373639, PMID 34389161, PMID 42312676